Discover how oncology nurses can make a profound impact beyond the bedside by registering as stem cell and bone marrow donors to save lives.

Handa Oncology received FDA tentative approval for Omcazio capsules, a novel cabozantinib formulation with improved absorption and no food effects. The FDA approved zidesamtinib for metastatic ...

Learn how supportive culture and connection can improve oncology nurse retention and address burnout, shifting focus from individual responsibility. What if the solution to retention is not asking ...

Oncology dietitian Gabrielle Raucci explores the role of creatine in cancer care, highlighting when to use it and risks during active treatment.

Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...

The FDA has approved perioperative pembrolizumab and enfortumab vedotin for adult patients with muscle-invasive bladder ...

New research identifies treatment initiation thresholds that impact 3-year metastasis risk in colorectal cancer patients across distinct pathways. For oncology care teams, the coordination of care is ...

NYU Langone experts discuss multidisciplinary care, diagnostic challenges, and nursing's role in treating rare bone and soft tissue sarcomas.

NYU Langone experts discuss multidisciplinary care, diagnostic challenges, and nursing's role in treating rare bone and soft tissue sarcomas.

The US Food and Drug Administration (FDA) has granted approval for zidesamtinib (Jideytro), a next-generation ROS1-selective inhibitor, for the treatment of adult patients with locally advanced or ...

Stephanie Desrosiers discusses strategies for oncology nurses to manage chemotherapy shortages, ensuring patient safety, ...

A 10-year study of 3,477 patients reveals focal therapy offers high survival and low metastasis for localized prostate cancer with few side effects. A landmark multicenter study published in European ...